KANNEMEIER CHRISTIAN
No ORCID on file
· 46 papers in corpus
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
2003
Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…